Jane Street
VIR icon

Jane Street’s Vir Biotechnology VIR Stock Holding History

Jane Street’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-66,344
Closed -$631K – 13240
2026
Q1 		$594K Sell
66,344
-197,662
-75% -$1.58M ﹤0.01% 7647
2025
Q4 		$1.59M Buy
264,006
+191,766
+265% +$1.14M ﹤0.01% 5237
2025
Q3 		$412K Buy
+72,240
New +$369K ﹤0.01% 8262
2025
Q2 		– Sell
-18,252
Closed -$118K – 11010
2025
Q1 		$118K Sell
18,252
-124,825
-87% -$1.11M ﹤0.01% 8728
2024
Q4 		$1.05M Buy
143,077
+12,730
+10% +$100K ﹤0.01% 5292
2024
Q3 		$976K Sell
130,347
-62,104
-32% -$539K ﹤0.01% 5937
2024
Q2 		$1.71M Buy
192,451
+91,941
+91% +$882K ﹤0.01% 4765
2024
Q1 		$1.02M Buy
100,510
+27,204
+37% +$277K ﹤0.01% 5380
2023
Q4 		$737K Buy
73,306
+44,845
+158% +$410K ﹤0.01% 6123
2023
Q3 		$267K Sell
28,461
-111,924
-80% -$1.6M ﹤0.01% 7240
2023
Q2 		$3.44M Buy
140,385
+101,410
+260% +$2.55M ﹤0.01% 3279
2023
Q1 		$907K Buy
38,975
+28,357
+267% +$725K ﹤0.01% 5183
2022
Q4 		$269K Sell
10,618
-61,994
-85% -$1.52M ﹤0.01% 7203
2022
Q3 		$1.4M Buy
72,612
+64,509
+796% +$1.64M ﹤0.01% 4817
2022
Q2 		$206K Sell
8,103
-122,518
-94% -$2.86M ﹤0.01% 8150
2022
Q1 		$3.36M Buy
130,621
+3,663
+3% +$109K ﹤0.01% 3728
2021
Q4 		$5.32M Buy
126,958
+91,287
+256% +$3.58M ﹤0.01% 2763
2021
Q3 		$1.55M Buy
35,671
+15,926
+81% +$690K ﹤0.01% 5005
2021
Q2 		$933K Buy
+19,745
New +$898K ﹤0.01% 5988
2021
Q1 		– Sell
-26,579
Closed -$1.43M – 9631
2020
Q4 		$712K Sell
26,579
-3,945
-13% -$128K ﹤0.01% 5200
2020
Q3 		$1.05M Sell
30,524
-25,102
-45% -$1.08M ﹤0.01% 4024
2020
Q2 		$2.28M Buy
+55,626
New +$1.87M ﹤0.01% 2880

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jane Street's VIR Position: Q2 2026 in Review

Jane Street sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 66,344 shares — an estimated $631K sold.

Jane Street first reported a position in VIR in Q2 2020 and held it in 22 quarters. The position peaked at $5.32M in Q4 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Jane Street reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 66,344 Vir Biotechnology shares in Q2 2026, an estimated $631K.
  • Jane Street first reported a position in Vir Biotechnology in Q2 2020 and held it in 22 quarters.
  • Jane Street's Vir Biotechnology position peaked at $5.32M in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.